Wednesday, May 22 2019 | Time 14:50 Hrs(IST)
image
  • All eyes on West Bengal as exit polls challenge Mamata
  • Cop held for graft in Aurangabad
  • Nepal bans China‚Äôs Alipay and WeChat digital wallets
  • J&K Guv apologises to public on Kashmir highway ban, says decision taken in national interest
  • HP: Counting of votes from 0800 hrs on Thursday
  • One dies in bomb blast and 20 arrested in volatile Bhatpara; Repoll on at Jorasanko
  • Anti-Sterlite Protests: First anniversary of death of 13 people in police firing observed
  • Rahul cautions Congress workers, says next 24 hrs crucial
  • Austrian president consoles public in wake of coalition gov't collapse
  • Stage set for counting of votes in Telangana tomorrow
  • SC stays BJP candidate's arrest till May 28
  • Huge explosion rocks Mogadishu, casualties feared
  • Yemen's Houthi rebels launch fresh drone attack on Saudi Najran airport
  • Local Taliban leader among 16 militants killed in Afghanistan
  • No IED blast on LoC, soldiers injured in training event in Poonch: Army
Business Economy


Maruti Suzuki Feb 2019 sales marginally up 0.89 percent

Maruti Suzuki Feb 2019 sales marginally up 0.89 percent

Mumbai, Mar 1 (UNI) Passenger vehicle major, Maruti Suzuki has reported a marginal increase of 0.89 per cent in its domestic sales at 139,100 units in February as compared with 137,900 units sold in corresponding period in 2018.

Maruti, however, saw a marginal decline of 0.8 per cent in its total sales (domestic+exports) at 148,682 units last month as against 149,824 units sold in the in the corresponding month last year, a release said

Company's light commercial vehicle dispatch 2,188 units in the month under review witnessing a jump of 74.8 per cent.

Total exports saw a declined of 19.6 per cent at 9,582 units in February 2019 as compared to 11,924 units in the February year ago.

Sales of the Alto and WagonR dipped 26.7 percent from 33,789 units sold in February 2018 to 24,751 units sold in the past month. However, sales of cars in the compact segment which included the new WagonR, Celerio, Ignis, Swift, Baleno and DZire saw a surge of 11.4 per cent. A total of 65,213 units were sold in February 2018 which increased to 72,678 units in February 2019.

Sales of the Ciaz also went down by 37.0 percent from 4,897 units sold in February 2018 to 3,084 units sold in the past month taking total passenger sales down 3.3 percent from 1,03,899 units in February 2018 to 1,00,513 units in the past month. The utility vehicle segment, comprising the Gypsy, Ertiga, Brezza and S-Cross saw a surge in sales by 7.4 percent with a total of 21,834 units sold in February 2019 as compared to 20,324 units sold in the same month of the previous year.

Omni and Eeco sales also increased by 17.2 per cent from 12,425 units in February 2018 to 14,565 units in the past month. In the light commercial vehicle segment, sales of the Super Carry went up 74.8 per cent from 1,252 units sold in February 2018 to 2,188 units sold in February 2019.

UNI JS NV SV 1443

More News

Kozhikode Oil Market

22 May 2019 | 2:43 PM

Kozhikode, May 22 (UNI) Following were the rates in the
Kozhikode Oil Market today per quintal.

see more..

Kozhikode Spices market

22 May 2019 | 2:42 PM

Kozhikode, May 22 (UNI) Following were the rates in the
Kozhikode Spices market today per quintal.

see more..

Kozhikode Rubber Market

22 May 2019 | 2:40 PM

Kozhikode, May 22 (UNI) Following was the rate in the Kozhikode
Rubber Market today,
RMA LOT (RSS-4)13,850,(RSS-5)12,800.

see more..
Sugar rates steady in Kolhapur market

Sugar rates steady in Kolhapur market

22 May 2019 | 1:08 PM

Kolhapur, May 22 (UNI) The prices of M 30 and S 30 grades of sugar rates remained steady in Kolhapur sugar market on Wednesday at Rs 3280/3300 and Rs 3180/3200 per quintal respectively.

see more..

Panacea Biotec receives USFDA approval for manufacture, supply of Azacitidine for US market

22 May 2019 | 12:53 PM

Mumbai, May 22 (UNI) Pharma Major, Panacea Biotec said that company's Oncology Parenteral Formulation Facility at Baddi, Himachal Pradesh has received United States Food & Drug Administration (USFDA) approval for manufacture and supply of Azacitidine Injection, 100 mg/vial, for the US market.

see more..
image